Home » Market News » DirectorsTalk Highlights » INTERVIEW: Evgen Pharma Plc Outlook is very good say Northland Capital
Evgen Pharma Plc

INTERVIEW: Evgen Pharma Plc Outlook is very good say Northland Capital

Evgen Pharma Plc (LON:EVG) is the topic of conversation when Vadim Alexandre, Head of Research at Northland Capital Partners joins DirectorsTalk. With Evgen proving it’s interim results and notice of a successful placing Vadim shares his view on the company’s outlook moving into 2018.

 

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.